Transgene Biotek Ltd - Shs Dematerialised

BOM:526139 (India)   Shs Dematerialised
₹ 7.76 (+0.91%) Oct 11
At Loss
P/B:
4.13
Market Cap:
₹ 587.98M ($ 6.99M)
Enterprise V:
₹ 727.91M ($ 8.65M)
Volume:
28.31K
Avg Vol (2M):
39.83K
Trade In:
Volume:
28.31K
At Loss

Business Description

Description
Transgene Biotek Ltd is an India-based research and development company. It is engaged in the research and development of molecules and technologies for the production of active pharmaceutical ingredients and different products. The Company is operating only in one segment of Bulk Drugs. The group's product portfolio includes TrabiDHA, Tracolimus, and Orlistat. It generates revenue from the provision of medical diagnostic services, research and development, and sales of products.
Name Current Vs Industry Vs History
Equity-to-Asset 0.08
Debt-to-Equity 1.31
Debt-to-EBITDA -105.35
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.18
Distress
Grey
Safe
Beneish M-Score 0.73
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 49.3
9-Day RSI 44.88
14-Day RSI 42.46
12-1 Month Momentum % 95.65

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.1
Quick Ratio 0.1
Days Inventory 24722.67
Days Sales Outstanding 16.64
Days Payable 152983.67

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio 1.3
Shareholder Yield % -1.61

Financials

BOM:526139's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Transgene Biotek Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₹) 1.842
EPS (TTM) (₹) -0.05
Beta 2.14
Volatility % 110.28
14-Day RSI 42.46
14-Day ATR (₹) 0.57674
20-Day SMA (₹) 7.836
12-1 Month Momentum % 95.65
52-Week Range (₹) 3.84 - 12.46
Shares Outstanding (Mil) 75.77

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Transgene Biotek Ltd Filings

Filing Date Document Date Form
No Filing Data

Transgene Biotek Ltd Stock Events

Financials Calendars
Event Date Price(₹)
No Event Data

Transgene Biotek Ltd Frequently Asked Questions

What is Transgene Biotek Ltd(BOM:526139)'s stock price today?
The current price of BOM:526139 is ₹7.76. The 52 week high of BOM:526139 is ₹12.46 and 52 week low is ₹3.84.
When is next earnings date of Transgene Biotek Ltd(BOM:526139)?
The next earnings date of Transgene Biotek Ltd(BOM:526139) is .
Does Transgene Biotek Ltd(BOM:526139) pay dividends? If so, how much?
Transgene Biotek Ltd(BOM:526139) does not pay dividend.

Press Release

Subject Date
No Press Release